Published in Gastroenterol Res Pract on September 26, 2010
Ajuba family proteins link JNK to Hippo signaling. Sci Signal (2013) 1.90
Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools. Front Immunol (2014) 0.92
High-throughput analysis of tumor necrosis factor signaling pathways in eight cell types during rat hepatic regeneration. Inflammation (2012) 0.78
XAGE-1b expression is associated with the diagnosis and early recurrence of hepatocellular carcinoma. Mol Clin Oncol (2014) 0.77
Proliferation of mouse liver stem/progenitor cells induced by plasma from patients with acute liver failure is modulated by P2Y2 receptor-mediated JNK activation. J Gastroenterol (2013) 0.77
Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes. Arch Toxicol (2015) 0.75
P2Y2 nucleotide receptor activation enhances the aggregation and self-organization of dispersed salivary epithelial cells. Am J Physiol Cell Physiol (2014) 0.75
Alleviative effects from boswellic acid on acetaminophen-induced hepatic injury. Biomedicine (Taipei) (2016) 0.75
Toll-like receptors in pathophysiology of liver diseases. World J Hepatol (2016) 0.75
Weight loss following diet-induced obesity does not alter colon tumorigenesis in the AOM mouse model. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Pathogen recognition and innate immunity. Cell (2006) 44.14
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity (1998) 18.12
JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell (1994) 16.30
NF-kappaB at the crossroads of life and death. Nat Immunol (2002) 12.98
Liver regeneration. Science (1997) 12.80
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science (1995) 11.38
Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 11.24
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature (1995) 10.36
AP-1 as a regulator of cell life and death. Nat Cell Biol (2002) 10.10
IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell (2005) 8.78
Liver regeneration. Hepatology (2006) 7.52
Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med (2007) 7.25
Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol (2004) 6.36
Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell (2007) 5.91
JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev (1994) 4.50
Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell (2004) 3.94
Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol (2010) 3.77
Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol (2009) 3.55
c-jun is essential for normal mouse development and hepatogenesis. Nature (1993) 3.43
Stem cells and liver regeneration. Gastroenterology (2009) 3.40
Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci U S A (2006) 3.33
A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev (1993) 3.21
Met provides essential signals for liver regeneration. Proc Natl Acad Sci U S A (2004) 2.77
Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc Natl Acad Sci U S A (2009) 2.68
Functional analysis and regulation of nuclear import of dorsal during the immune response in Drosophila. EMBO J (1995) 2.48
The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med (2003) 2.38
NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest (1998) 2.27
Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex. Mol Cell Biol (1992) 2.27
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest (2008) 2.26
Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J (2002) 2.15
Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology (2001) 2.14
The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ (2006) 2.08
The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci U S A (2007) 2.00
c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology (2003) 1.87
SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc Natl Acad Sci U S A (1998) 1.78
Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology (2009) 1.73
Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity (1999) 1.67
Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J Biol Chem (1994) 1.64
Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest (2002) 1.58
Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development (1999) 1.56
Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice. Proc Natl Acad Sci U S A (2002) 1.51
Sequential protooncogene expression during rat liver regeneration. Cancer Res (1986) 1.42
Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology (1990) 1.36
Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology (2005) 1.33
Activation of Jun kinase is an early event in hepatic regeneration. J Clin Invest (1995) 1.28
Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. Hepatology (1995) 1.28
Proinflammatory cytokine production in liver regeneration is Myd88-dependent, but independent of Cd14, Tlr2, and Tlr4. J Immunol (2006) 1.25
Gadd45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling. J Clin Invest (2008) 1.23
Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology (2004) 1.23
JNK2: a negative regulator of cellular proliferation. Cell Cycle (2004) 1.23
Mechanisms of liver disease: cross-talk between the NF-kappaB and JNK pathways. Biol Chem (2009) 1.18
Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int (2005) 1.13
Liver regeneration is suppressed in small-for-size liver grafts after transplantation: involvement of c-Jun N-terminal kinase, cyclin D1, and defective energy supply. Transplantation (2006) 1.11
Toll-like receptor 3 signaling attenuates liver regeneration. Hepatology (2009) 1.06
Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration. J Biol Chem (2003) 1.05
Hepatocyte-specific inhibitor-of-kappaB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration. Hepatology (2008) 1.04
Gut-derived endotoxin elicits hepatotrophic factor secretion for liver regeneration. Am J Physiol (1985) 1.03
Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha/kallikrein-mediated activation of latent TGF-beta. Gastroenterology (2002) 1.01
Transient induction of c-jun during hepatic regeneration. Hepatology (1990) 0.99
NF-kappaB activation in Kupffer cells after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol (2005) 0.94
Dominant-negative TAK1 induces c-Myc and G(0) exit in liver. Am J Physiol Gastrointest Liver Physiol (2001) 0.90
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol (2008) 3.27
Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol (2002) 2.61
A novel 3D hepatectomy simulation based on liver circulation: application to liver resection and transplantation. Hepatology (2005) 1.97
Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma. World J Surg (2007) 1.35
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth. J Cell Sci (2004) 1.34
Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology (2005) 1.33
Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer (2003) 1.32
Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut (2006) 1.31
LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis. FEBS Lett (2006) 1.30
Coexpression of Gas6/Axl in human ovarian cancers. Oncology (2004) 1.23
Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis. Am J Physiol Gastrointest Liver Physiol (2007) 1.15
Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse. J Exp Med (2004) 1.12
Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation. Nat Med (2008) 1.09
Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings. J Hepatol (2007) 1.06
Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model. Hepatology (2003) 1.04
Phosphorylation of highly conserved neurofilament medium KSP repeats is not required for myelin-dependent radial axonal growth. J Neurosci (2009) 1.04
Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF signalling. Genes Cells (2004) 1.00
The impact of 3-D virtual hepatectomy simulation in living-donor liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.00
Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice. J Hepatol (2009) 0.99
Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Hepatology (2013) 0.96
Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer (2009) 0.96
Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice. J Hepatol (2006) 0.95
Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women. Steroids (2003) 0.94
Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers. J Steroid Biochem Mol Biol (2007) 0.94
Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers. J Biomed Sci (2007) 0.93
Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int (2002) 0.91
Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes. Am J Pathol (2005) 0.91
Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats. Am J Pathol (2007) 0.90
Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes. Surgery (2008) 0.90
Hemodynamic analysis and treatment of an enlarging extrahepatic portal aneurysm: report of a case. Surg Today (2014) 0.90
Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma. Surg Today (2005) 0.90
New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. J Gastroenterol (2013) 0.89
Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20. Pancreas (2009) 0.88
Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model. Am J Physiol Gastrointest Liver Physiol (2004) 0.88
Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway. Lab Invest (2011) 0.87
Role of innate immune response in liver regeneration. J Gastroenterol Hepatol (2007) 0.87
Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci (2010) 0.87
Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers. Gynecol Oncol (2009) 0.87
Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. J Rheumatol (2003) 0.87
Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Res Ther (2006) 0.86
Laparoscopic management of giant splenic true cyst with partial splenectomy: a case report. Asian J Endosc Surg (2013) 0.86
The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice. Gastroenterol Res Pract (2010) 0.85
Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count. Hepatol Res (2013) 0.85
Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation. Blood (2004) 0.85
Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis. Surg Today (2013) 0.85
Primary squamous cell carcinoma of the liver: an uncommon finding in contrast-enhanced ultrasonography imaging. Case Rep Gastroenterol (2011) 0.85
c-Jun N-terminal kinase activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of retinoic acid receptor α protein in hepatic cells. Cancer Sci (2011) 0.84
Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci (2003) 0.84
Strategy of gene therapy for liver cirrohosis and hepatocellular carcinoma. J Hepatobiliary Pancreat Surg (2003) 0.84
Minimally invasive laparoscopic liver resection: 3D MDCT simulation for preoperative planning. J Hepatobiliary Pancreat Surg (2009) 0.84
Hepatocyte growth factor gene transfer with naked plasmid DNA ameliorates dimethylnitrosamine-induced liver fibrosis in rats. Hepatol Res (2008) 0.83
Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene. FEBS Lett (2012) 0.83
Angiogenesis is crucial for liver regeneration after partial hepatectomy. Surgery (2012) 0.83
Adeno-associated virus vector-mediated production of hepatocyte growth factor attenuates liver fibrosis in mice. Hepatol Int (2007) 0.83
Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers. Oncology (2008) 0.82
Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers. Cancer Sci (2003) 0.82
Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. Gynecol Oncol (2004) 0.82
Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis. Hepatol Res (2011) 0.82
Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers. Cancer Lett (2006) 0.82
Granulocyte-colony stimulating factor-producing gallbladder carcinoma. Int Surg (2014) 0.81
Reactive oxygen species modify oligosaccharides of glycoproteins in vivo: a study of a spontaneous acute hepatitis model rat (LEC rat). Biochem Biophys Res Commun (2006) 0.80
Successful liver resection for biliary atresia with intrahepatic biliary cysts after Kasai procedure. J Pediatr Surg (2005) 0.80
Successful living related liver transplantation for adult Still's disease. J Gastroenterol Hepatol (2003) 0.79
Hepatocyte growth factor promotes remodeling of murine liver fibrosis, accelerating recruitment of bone marrow-derived cells into the liver. Hepatol Res (2007) 0.79
Randomized Controlled Trial of Pancreaticojejunostomy versus Stapler Closure of the Pancreatic Stump During Distal Pancreatectomy to Reduce Pancreatic Fistula. Ann Surg (2016) 0.79
Frequent polymorphic changes but rare tumor specific mutations of the LATS2 gene on 13q11-12 in esophageal squamous cell carcinoma. Int J Oncol (2002) 0.79
Primary epithelioid hemangioendothelioma of the retroperitoneum: report of a case. Surg Today (2012) 0.79
Multivariate logistic regression analysis for prediction of clinically relevant pancreatic fistula in the early phase after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci (2013) 0.79
Sectionectomy of the liver. J Hepatobiliary Pancreat Sci (2012) 0.78
Role of inhibitor of DNA binding-1 protein is related to angiogenesis in the tumor advancement of uterine endometrial cancers. Exp Ther Med (2010) 0.78
Solitary mediastinal metastasis of hepatocellular carcinoma treated by video-assisted thoracic surgery: report of a case. Gen Thorac Cardiovasc Surg (2012) 0.78
Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers. Oncol Rep (2007) 0.77
Role of c-kit receptor tyrosine kinase-mediated signal transduction in proliferation of bile epithelial cells in young rats after ligation of bile duct: a study using Ws/Ws c-kit mutant rats. J Hepatol (2003) 0.77
Treating liver cirrhosis in dogs with hepatocyte growth factor gene therapy via the hepatic artery. J Hepatobiliary Pancreat Surg (2009) 0.77
Transfection of NF-kappaB decoy oligodeoxynucleotides into macrophages reduces murine fatal liver failure after excessive hepatectomy. J Surg Res (2008) 0.77
In vivo effect of imatinib on progression of cecal GIST-like tumors in exon 17-type c-kit knock-in mice. Lab Invest (2009) 0.77
Hepatic effects of influxed endothelin-1 from portal vein: in situ portal vein infusion model using dogs. J Hepatobiliary Pancreat Surg (2006) 0.76
Expression of E26 transformation specific (ETS-1) related to angiogenesis in ovarian endometriosis. Fertil Steril (2004) 0.76
Delayed arterial hemorrhage after pancreaticoduodenectomy. Int Surg (2014) 0.75
Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers. BMC Cancer (2008) 0.75
Granulocyte colony-stimulating factor-producing cholangiocellular carcinoma. Int Surg (2015) 0.75
Perioperative and Long-term Outcome of the Warshaw Technique in Laparoscopic Spleen-preserving Distal Pancreatectomy. Surg Laparosc Endosc Percutan Tech (2017) 0.75
Quantitative analysis of estrogen receptor proteins in rat ovary. J Steroid Biochem Mol Biol (2005) 0.75
Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease. Am J Physiol Gastrointest Liver Physiol (2007) 0.75
Sex steroids in uterine endometrial cancers. Horm Mol Biol Clin Investig (2011) 0.75
Primary adenocarcinoma of the minor duodenal papilla with mass-forming chronic pancreatitis: report of a case. Surg Today (2014) 0.75
Salvage treatment of laparoscopic cholecystectomy-associated bile duct stenosis combining laparoscopic and endoscopic procedures: a case report. Asian J Endosc Surg (2013) 0.75
Outcomes of hepatic resection for large hepatocellular carcinoma: special reference to postoperative recurrence. Am Surg (2015) 0.75
[Gene therapy for hepatocellular carcinoma]. Nihon Rinsho (2005) 0.75
Effects of various steroids on platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA expression in uterine endometrial cancer cells. J Steroid Biochem Mol Biol (2003) 0.75
Hepatic venoplasty to overcome outflow block in living related liver transplantation. J Pediatr Surg (2004) 0.75
Development of hepatocellular carcinoma in cardiac congestive liver fibrosis: report of a case. Clin J Gastroenterol (2015) 0.75
Non-B non-C Hepatocellular Carcinoma: the Risk Factors for Recurrence and the Types of Recurrence Following Hepatic Resection. Hepatogastroenterology (2014) 0.75
Regional hepatic regeneration after liver resection correlates well with preceding changes in the regional portal circulation in humans. Dig Dis Sci (2013) 0.75
Analysis of unique liver volume restoration after laparoscopic fenestration of liver cysts. Asian J Endosc Surg (2014) 0.75
Prediction of Postoperative Hepatic Failure after Liver Resection for Hepatocellular Carcinoma: Significance of the Aspartate Aminotransferase-to-Platelet Ratio Index. Hepatogastroenterology (2014) 0.75
Impact of donor age on the growth of young recipient rats after liver transplantation. Surg Today (2006) 0.75
Angiomyolipoma of the liver presenting a homogeneously hypoechoic mass. J Gastroenterol (2005) 0.75
Parenteral nutrition administration leads to specific alterations in the expression of adipocytokines and peroxisome proliferator-activated receptors in a rat model. JPEN J Parenter Enteral Nutr (2011) 0.75